Influences of teriparatide administration on marrow fat content in postmenopausal osteopenic women using MR spectroscopy

References

• Nanes MS, Kallen CB. Osteoporosis. Semin Nucl Med 2014;44:439–50
   PubMed Web of Science ®Google Scholar
• Silva BC, Bilezikian JP. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr Opin Pharmacol 2015;22:41–50
   PubMed Web of Science ®Google Scholar
• Aslan D, Andersen MD, Gede LB, et al. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans. Scand J Clin Lab Invest 2012;72:14–22
   PubMed Web of Science ®Google Scholar
• Singhal V, Maffazioli GD, Cano Sokoloff N, et al. Regional fat depots and their relationship to bone density and microarchitecture in young oligo-amenorrheic athletes. Bone 2015;77:83–90
   PubMed Web of Science ®Google Scholar
• Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009;94:3387–93
   PubMed Web of Science ®Google Scholar
• Sadie-Van Gijsen H, Hough FS, Ferris WF. Determinants of bone marrow adiposity: the modulation of peroxisome proliferator-activated receptor-gamma 2 activity as a central mechanism. Bone 2013;56:255–65
   PubMed Web of Science ®Google Scholar
• Patel JJ, Butters OR, Arnett TR. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity. Cell Biochem Funct 2014;32:368–77
   PubMed Web of Science ®Google Scholar
• Li GW, Xu Z, Chen QW, et al. Quantitative evaluation of vertebral marrow adipose tissue in postmenopausal female using MRI chemical shift-based water-fat separation. Clin Radiol 2014;69:254–62
   PubMed Web of Science ®Google Scholar
• Cordes C, Dieckmeyer M, Ott B, et al. MR-detected changes in liver fat, abdominal fat, and vertebral bone marrow fat after a four-week calorie restriction in obese women. J Magn Reson Imaging 2015;42:1272–80
   PubMed Web of Science ®Google Scholar
• Baum T, Yap SP, Karampinos DC, et al. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus? J Magn Reson Imaging 2012;35:117–24
   PubMed Web of Science ®Google Scholar
• Rickard DJ, Wang FL, Rodriguez-Rojas AM, et al. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 2006;39: 1361–72
   PubMed Web of Science ®Google Scholar
• Lu R, Wang Q, Han Y, Li J, Yang XJ, Miao D. Parathyroid hormone administration improves bone marrow microenvironment and partially rescues haematopoietic defects in Bmi1-null mice. PLoS One 2014;9:e93864
   Google Scholar
• Chan GK, Miao D, Deckelbaum R, Bolivar I, Karaplis A, Goltzman D. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells. Endocrinology 2003;144:5511–20
   PubMed Web of Science ®Google Scholar
• Sato M, Westmore M, Ma YL, et al. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res 2004;19:623–9
   PubMed Web of Science ®Google Scholar
• Pansini V, Monnet A, Salleron J, Hardouin P, Cortet B, Cotten A. 3 Tesla (1) H MR spectroscopy of hip bone marrow in a healthy population, assessment of normal fat content values and influence of age and sex. J Magn Reson Imaging 2014;39:369–76
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang X-J, Zhu X-J, et al. Comparison between recombinant human parathyroid hormone (1–34) and elcatonin in treatment of primary osteoporosis. Asian Pac J Trop Med 2015;8:79–84
   PubMed Web of Science ®Google Scholar
• Sone T, Ito M, Fukunaga M, et al. The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk. Bone 2014;64:75–81
   PubMed Web of Science ®Google Scholar
• Leder BZ, Tsai JN, Uihlein AV, et al. Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial. J Clin Endocrinol Metab 2014;99:1694–700
   PubMed Web of Science ®Google Scholar
• Bredella MA, Fazeli PK, Daley SM, et al. Marrow fat composition in anorexia nervosa. Bone 2014;66: 199–204
   PubMed Web of Science ®Google Scholar
• Bredella MA, Gill CM, Gerweck AV, et al. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology 2013;269:534–41
   PubMed Web of Science ®Google Scholar
• Ghali O, Broux O, Falgayrac G, et al. Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation. BMC Cell Biol 2015;16:9
   PubMed Web of Science ®Google Scholar
• Liu L, Aronson J, Huang S, et al. Rosiglitazone inhibits bone regeneration and causes significant accumulation of fat at sites of new bone formation. Calcif Tissue Int 2012;91:139–48
   PubMed Web of Science ®Google Scholar
• Li GW, Xu Z, Chang SX, et al. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats. Endocrinology 2014;155:4731–8
   PubMed Web of Science ®Google Scholar
• Patsch JM, Li X, Baum T, et al. Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res 2013;28:1721–8
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang FJ, Zhao WJ, Xing GS, Bai X, Wang Y. Effects of parathyroid hormone-related protein on osteogenic and adipogenic differentiation of human mesenchymal stem cells. Eur Rev Med Pharmacol Sci 2014;18:1610–17
   PubMed Web of Science ®Google Scholar
• Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karaplis AC. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology 2001;142:4900–9
   PubMed Web of Science ®Google Scholar
• Karampinos DC, Melkus G, Baum T, Bauer JS, Rummeny EJ, Krug R. Bone marrow fat quantification in the presence of trabecular bone: Initial comparison between water-fat imaging and single-voxel MRS. Magn Reson Med 2014;71:1158–65
   PubMed Web of Science ®Google Scholar
• Li X, Kuo D, Schafer AL, et al. Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging 2011;33:974–9
   PubMed Web of Science ®Google Scholar